Skip to main content
Neuro-Oncology logoLink to Neuro-Oncology
. 2016 Jul 26;18(9):1329. doi: 10.1093/neuonc/now142

Corrigendum

PMCID: PMC4999006  PMID: 27563107

Corrigendum to Frühwald et al. Atypical teratoid/rhabdoid tumors—current concepts, advances in biology, and potential future therapies. Neuro Oncol (2016) 18 (6): 764–778 first published online January 10, 2016 doi:10.1093/neuonc/nov264.

On page 765, the sentence “Radiation at any time during therapy (adjuvant or salvage) significantly influenced survival (median survival 17.8 mo vs 14 mo; P = .64)” should have read as follows:

Radiation at any time during therapy (adjuvant or salvage) did not significantly influence survival (median survival 17.8 mo vs 14 mo; P = .64).

The authors apologize for this error.


Articles from Neuro-Oncology are provided here courtesy of Society for Neuro-Oncology and Oxford University Press

RESOURCES